手术切除联合射频消融治疗结肠癌肝转移疗效分析

doi:10.3969/j.issn.1672-5069.2016.03.018

摘要/Abstract

摘要： 目的探讨手术联合射频消融治疗结肠癌肝转移患者的治疗效果。方法对2008年1月至2014年3月我科诊治的结肠癌肝转移接受结肠癌根治术和肝内肿瘤灶切除治疗的17例和结肠癌根治术后对肝内肿瘤行射频消融（RFA）治疗的12例患者的临床资料进行回顾性分析。绘制Kaplan-Meier生存曲线，进行生存分析。结果单纯手术治疗的17例患者均于术后20个月内死亡，平均生存时间为（13.412±0.912）月，而手术联合射频消融治疗的12例患者随访6~28个月，平均生存时间为（18.496±2.139）月（P<0.05）；RFA治疗后患者均出现不同程度的恶心、呕吐、胸闷、右上腹痛、发热，血清ALT和AST轻度升高。结论手术联合射频消融治疗结肠癌肝转移是一种可行的、安全的、有效的方法，可以明显延长患者的生存期。

关键词: 结肠癌, 肝转移癌, 手术切除, 射频消融

Abstract: Objective To investigate the efficacy of radiofrequency ablation after resection of colorectal caicinomain patients with liver metastases. Methods 17 patients with colorectal liver metastases had radical operation and hepatolobectomy and 12 had radical operation and radiofrequency ablation （RFA） from January 2008 to March 2014 in our series. Their clinical materials was retrospectively analyzed， and the survival curve was drawn by the Kaplan Meier. Results All the patients in radical operation and hepatolobectomy died within 20 months after surgery，and the average survival time was （13.412±0.912） months. The patients receiving RFA was followed-up for 6 to 28 months，and the average expected survival time was（18.496±2.139） months，which was significantly longer than in hepatolobectomy group（P<0.05）. Conclusion The radical operation and radiofrequency ablation for treating colorectal liver metastases is feasible，safe and effective， and it can obviously prolong the patient's survivals.

Key words: Liver metastases, Colorectal cancer, Radical operation, Radiofrequency ablation

安永德，郭亚民，范龙鑫. 手术切除联合射频消融治疗结肠癌肝转移疗效分析[J]. 实用肝脏病杂志, 2016, 19(3): 327-330.

An Yongde,GuoYamin,Fan Longxin. Efficacy of radiofrequency ablation after resection of colorectal caicinomain patients with liver metastases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 327-330.

参考文献

[1] 刘金有. MRI诊断肝转移瘤的价值探讨.实用肝脏病杂志， 2011，14（1）:42-44.
[2] 许永华，徐敬慈，杨利霞，等. 应用MRI弥散成像表观弥散系数监测肝转移瘤化疗疗效研究.实用肝脏病杂志，2012，15（5）: 421-423.
[3] 顾晋，王林. 美国结直肠外科医师协会结肠癌治疗规范（2012版）精要及解读.中华胃肠外科杂志，2012，15（10）:997-999.
[4] Wang CC，Li J. An update on chemotherapy of colorectal liver metastases. World J Gastroenterol，2012，18（1）:25-33.
[5] Munene G，Parker RD，Shaheen AA，et al. Disparitiesin the surgical treatment of colorectal liver metastases. J Natl Med Assoc，2013，105（2）:128-137.
[6] 黄建钊，刘江伟，孙倩，等. 射频消融与手术切除治疗肝癌的疗效比较.广东医学，2012，33（13）:1991-1993.
[7] Xu J，Qin X，Wang J，et al. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol，2011，137（9）:1379-1396.
[8] 王新团，耿智敏，工华. 一期切除结直肠癌并发肝转移癌的临床应用. 实用肝脏病杂志，2015，18（4）:422-423.
[9] 葛勇胜，马金良，芙卫东，等. 经皮联合开腹微波消融术治疗多发危险部位肝脏转移瘤疗效分析.实用肝脏病杂志，2015，18（3）:233-236.
[10] 李双生，吕维富，张止峰，等. 消化道肿瘤肝转移介入治疗的临床应用及预后分析. 实用肝脏病杂志，2008，11（6）:388-390.
[11] Cucchetti A，Piscaglia F，Cescon M，et al. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol，2013，19（26）:4106-4118.
[12] Sainani NI，Gervais DA，Mueller PR，et al. Imaging after percutane.ous radiofrequency ablation of hepatic tumors:Part 2，Abnormal findings. AJR，2013，200（1）:194-204.
[13] Solbiati L，Ahmed M，Cova L，et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology，2012，265（3）:958-968.
[14] 张跃伟. 微创介入治疗肝癌对机体免疫功能影响的研究现状与展望. 实用肝脏病杂志，2014，17（3）:231-234.
[15] 李刚，寸英丽，杨丽春. 肝癌患者射频消融后血清Th1、Th2型细胞因子的变化.肝胆胰外科杂志，2010，22（2）:94-96.
[16] 杜清华，李霄，王振东，等. 肝癌射频消融与手术切除对机体抗肿瘤免疫状态的影响.安徽医药，2010，14（11）:1317-1319.
[17] 张志刚，张跃伟. 肝癌微创治疗对机体T淋巴细胞亚群影响的研究现状. 中华肿瘤防治杂志，2012，19（12）:609-612.
[18] Xia JZ，Xie FL，RanLF，et al. High-intensity focused ultra-sound ablation activates autologous tumor-specific_cyotoxic T lymphocytes.Ultrasound Med Biol，2012，38（8）:1363-1371.
[19] Minami Y，Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer:a literature review. Gut Liver，2013，7（1）:1-6.
[20] Ungureanu BS，Sandulescu L，Surlin V，et al. Surgical hepatic resection vs. ultrasonographic guided radiofrequency ablation in colorectal liver metastases:what should we choose Med Ultrason， 2014，16（2）:145-151.
[21] Snoeren N，Nijkamp MW，Berendsen T，et al. Multipolar radiofrequency ablation for colorectal liver metastases close to major hepatic vessels.Surgeon，2015，13（2）:77-82.
[22] Meriggi F，Bertocchi P，Zaniboni A. Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg，2013，27（5）:138-145.